Study Confirms Effectiveness of Trilaciclib for Treatment of Patients with Extensive-Stage Small Cell Lung Cancer Co-authored by Florida Cancer Specialists & Research Institute Physicians and Senior Leaders
- Monday, July 31, 2023, 7:12
- Business
- Add a comment
Data confirms findings of FCS clinical research FORT MYERS, Fla., July 31, 2023 /PRNewswire/ — Florida Cancer Specialists & Research Institute, LLC (FCS) physicians and senior leaders are co-authors of a study that confirms the effectiveness of trilaciclib for the treatment of adult…
About the Author
adminasapcorp has written 38936 stories on this site.